Purple Biotech Ltd. (PPBT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.12M | -1.04M | -1.01M | -1.54M | -1.98M | -2.01M | -3.29M | -3.98M | -5.08M | -4.98M | -3.66M | -5.22M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -57.79% | 48.34% | 69.38% | 61.17% | 61.08% | 59.57% | 9.87% | 23.88% | 16.19% | -18.22% | -0.97% | -41.16% |
| Net Income | -89K | -23.89M | -1.31M | -1.09M | -456K | -415K | -668K | -2.42M | -3.78M | -4.86M | -5.05M | -5.16M |
| Depreciation & Amortization | 65K | 0 | 58.27K | 47K | 45K | 40K | 49K | 49K | 48K | 48K | 50K | 53K |
| Stock-Based Compensation | 93K | 0 | 0 | 59K | 93K | -34K | 132K | 218K | 266K | 181K | 449K | 493K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.16M | 20.95M | 193.91K | -146K | -950K | -601K | -1.47M | -773K | -685K | -1.41M | -692K | 25K |
| Working Capital Changes | -1.03M | 1.9M | 48.12K | -415K | -710K | -1M | -1.34M | -1.05M | -930K | 1.06M | 1.59M | -634K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.24M | 1.3M | -21.58K | -229K | -592K | -448K | -1.14M | -444K | -46K | 919K | 1.04M | -878K |
| Cash from Investing | 45K | -156.79K | 325.13K | 107K | 257K | 38K | 72K | 87K | 312K | 74K | 1.01M | 198K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | -1K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 6.04K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 43K | 5.03K | 2.02K | 38K | 36K | 38K | 75K | 82K | 312 | 80K | 127K | 196K |
| Cash from Financing | -64K | 317.99K | 5.59M | 366K | 103K | 3.94M | 2.13M | 433K | 268K | 4.25M | 572K | 367K |
| Debt Issued (Net) | -59K | -61K | -64K | -39K | -53K | -48K | -44K | -46K | -45K | -42K | -42K | -42K |
| Equity Issued (Net) | 0 | 379.59K | 5.66M | 443K | 221K | 4.37M | 504K | 564K | 374K | 4K | 678K | 486K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -5K | -601 | -395 | -38K | -65K | -380K | 1.67M | -85K | -61K | 4.28M | -64K | -77K |
| Net Change in Cash | -3.15M | -875.16K | 4.86M | -1.04M | -1.63M | 1.96M | -1.09M | -3.46M | -4.5M | -615K | -2.1M | -4.68M |
| Free Cash Flow | -3.12M | 0 | 0 | -1.55M | -1.98M | -2.01M | -3.29M | -3.98M | -5.08M | -4.98M | -3.65M | -5.22M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -57.79% | 100% | 100% | 61.12% | 61.08% | 59.57% | 9.85% | 23.89% | 16.24% | -18.22% | -0.8% | -40.96% |
| FCF per Share | -671.62 | - | - | -5.65 | -7.51 | -9.82 | -19.02 | -28.88 | -37.49 | -38.64 | -33.48 | -49.74 |
| FCF Conversion (FCF/Net Income) | 36.29x | 0.04x | 0.77x | 1.39x | 4.39x | 4.91x | 4.97x | 1.65x | 1.35x | 1.03x | 0.73x | 1.02x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |